Problems of Reformulating T4 tablets: Recently in... - Thyroid UK

Thyroid UK

139,912 members164,449 posts

Problems of Reformulating T4 tablets

diogenes profile image
diogenesRemembering
7 Replies

Recently in France, a reformulation of T4 tablets caused a sudden upsurge in adverse responses. We study the research justifying this change, and explored the reasons why such problems arose. We wrote a letter to the journal Clinical Theraputics examining the basis of why this event occurred. This has been accepted. If TUK posters want to look at what we wrote, I have sent Louise Roberts at TUK a copy.

Written by
diogenes profile image
diogenes
Remembering
To view profiles and participate in discussions please or .
Read more about...
7 Replies
Nanaedake profile image
Nanaedake

That's great. There needs to be much better understanding of manufactured thyroid hormone so our complaints when changes are made to the tablets do not get ignored.

shaws profile image
shawsAdministrator

Thanks for the information and I think it disgraceful that the patients have to have 'adverse' reactions before they, themselves, realise there may be changes within the fillers/binders of the tablet.

fuchsia-pink profile image
fuchsia-pink

As I recall, it also resulted in a HUGE class action against the manufacturer (google Merck / France/ levo) although Merck won the first court case, over damages

DippyDame profile image
DippyDame

Thank you.

Playing fast and loose with thyroid patients....yet again!

nightingale-56 profile image
nightingale-56

In 2010 my son and I suffered awful skin and soreness problems when we had our Goldshield Eltroxin changed for Merury Pharma. To date we are still suffering after having been to the Health Ombudsman and being told it is not in their remit. I also sent a yellow card to MHRA, who have not really answered this. I believe it was the fact that the acacia powder in it was heat-treated differently, but this has been denied. I am grateful for all the research you and your colleagues' do on our behalf. My apologies for the script, but my pc has just decided to change this and it might take me a while to find my usual one.

shaws profile image
shawsAdministrator

Thank you diogenes and thankfully TUK have scientists who know what they're talking about, rather than a doctor reducing doses due to a low TSH.

jgelliss profile image
jgelliss

Thank You Diogenes for another *Great Alert*. Do the manufacturers think thyroid patients are ignorant the way they would like us to be ???? We might be thyroid deficient and in many cases have no thyroid at all . But we know the difference from which thyroid meds works well for us and which are the thyroid meds that are "Insufficient" "Unacceptable" and are down right "Awful" because we have adverse affects from them. It's called in simple language that is thyroid language "Hypothyroidism". Stop fixing playing and wanting to do better . Because you just end up making it worse. In short *Stop Short Changing Us*. We know when you do …...

Any changes you make (manufacturers) is for Your Benefit to fill your pockets at *Our Expense* . Not For The Patients Benefit !!!!!!!!

Not what you're looking for?

You may also like...

Thanks to Lyn Mynott and staff of Thyroiduk.org

I have just listened to the Debate in Parliament regarding Liothyronine (T3) and it is thanks to...

T4 causing problems

Hi everyone, I wrote a few weeks ago about my endo. requesting I added T4 to my T3 only meds. I...

The effect of insufficient validation of thyroid assays

I wrote this rejoinder to a paper regarding the insufficient validation of thyroid function assays...

Another paper showing that free T3 is not normalised unless TSH is suppressed, in T4-therapy patients.

I'm just informing the TUK forum of the emergence of a new paper by Ito et al in the journal...

Reformulation of thyroxine tablets is not as easy as it looks

The makers of Euthyrox T4 tablets decided to reformulate and put outa paper justifying this as...